INT Medical shortens A-share listing resolution validity, plans auditor change and RMB1.43 billion guarantees

Bulletin Express11-17 22:41

Shanghai INT Medical Instruments Co., Ltd. (INT Medical) announced three board approvals dated 17 November 2026:

1. Compressed validity for A-share listing resolutions The Board reduced both the validity of the Issuance Resolution and the authorisation period for handling the ChiNext Market listing from 24 months to 12 months, counted from the forthcoming shareholders’ meeting approval. All other terms remain unchanged.

2. Planned domestic auditor replacement for FY 2026 To streamline work for the planned A-share offering, the Board will seek shareholder approval to replace KPMG Huazhen LLP with BDO China Shu Lun Pan Certified Public Accountants LLP as domestic auditor for 2026. • Expected audit fee: RMB0.50 million, up from RMB0.40 million for KPMG Huazhen in 2025, reflecting anticipated business expansion and a wider consolidation scope. • KPMG will continue as international auditor for Hong Kong Financial Reporting Standards. • Both the Board and KPMG Huazhen report no disagreements or unresolved issues related to the change.

3. Proposed RMB1.43 billion guarantees for six subsidiaries To support operating and financing needs, INT Medical plans to extend joint-and-several guarantees of up to RMB1.43 billion to six consolidated subsidiaries: • Shandong INT Medical Instruments – RMB0.70 billion • Hangzhou INT Medical Technology – RMB0.40 billion • Xiamen INT Medical Technology – RMB0.15 billion • Shanghai INT Purun Medical Instruments – RMB0.10 billion • Shanghai INT Biotechnology – RMB0.05 billion • Shanghai Qimu Medical Instruments – RMB0.03 billion

The guarantees do not constitute notifiable or connected transactions under Hong Kong Listing Rules.

A circular containing details of the auditor change and guarantees, plus the notice of the general meeting, will be dispatched to shareholders in due course.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment